Heikkilä Helka M, Hielm-Björkman Anna K, Innes John F, Laitinen-Vapaavuori Outi M
Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, P.O. Box 57, Helsinki, 00014, Finland.
Department of Musculoskeletal Biology, Institute of Aging and Chronic Disease and School of Veterinary Science, University of Liverpool, Chester High Road, Neston, CH64 7TE, UK.
BMC Vet Res. 2017 Mar 21;13(1):74. doi: 10.1186/s12917-017-0990-y.
Recently, intra-articular botulinum toxin A (IA BoNT A) has been shown to reduce joint pain in osteoarthritic dogs. Similar results have been reported in human patients with arthritis. However, the mechanism of the antinociceptive action of IA BoNT A is currently not known. The aim of this study was to explore this mechanism of action by investigating the effect of IA BoNT A on synovial fluid (SF) and serum substance P (SP), prostaglandin E (PGE), and tumor necrosis factor alpha (TNF-α) in osteoarthritic dogs. Additionally, the aim was to compare SF SP and PGE between osteoarthritic and non-osteoarthritic joints, and investigate associations between SP, PGE, osteoarthritic pain, and the signalment of dogs. Thirty-five dogs with chronic naturally occurring osteoarthritis and 13 non-osteoarthritic control dogs were included in the study. Osteoarthritic dogs received either IA BoNT A (n = 19) or IA placebo (n = 16). Serum and SF samples were collected and osteoarthritic pain was evaluated before (baseline) and 2 and 8 weeks after treatment. Osteoarthritic pain was assessed with force platform, Helsinki Chronic Pain Index, and joint palpation. Synovial fluid samples were obtained from control dogs after euthanasia. The change from baseline in SP and PGE concentration was compared between the IA BoNT A and placebo groups. The synovial fluid SP and PGE concentration was compared between osteoarthritic and control joints. Associations between SP, PGE, osteoarthritic pain, and the signalment of dogs were evaluated.
There was no significant change from baseline in SP or PGE after IA BoNT A. Synovial fluid PGE was significantly higher in osteoarthritic compared to control joints. Synovial fluid PGE correlated with osteoarthritic pain. No associations were found between SP or PGE and the signalment of dogs. The concentration of TNF-α remained under the detection limit of the assay in all samples.
The results suggest that the antinociceptive effect of IA BoNT A in the joint might not be related to the inhibition of SP nor PGE. Synovial fluid PGE, but not SP, could be a marker for chronic osteoarthritis and pain in dogs.
最近,关节内注射A型肉毒杆菌毒素(IA BoNT A)已被证明可减轻骨关节炎犬的关节疼痛。在患有关节炎的人类患者中也报道了类似的结果。然而,IA BoNT A的抗伤害感受作用机制目前尚不清楚。本研究的目的是通过研究IA BoNT A对骨关节炎犬滑液(SF)和血清中P物质(SP)、前列腺素E(PGE)以及肿瘤坏死因子α(TNF-α)的影响来探索其作用机制。此外,目的是比较骨关节炎关节和非骨关节炎关节之间的滑液SP和PGE,并研究SP、PGE、骨关节炎疼痛与犬的体征之间的关联。35只患有慢性自然发生的骨关节炎的犬和13只非骨关节炎对照犬被纳入研究。骨关节炎犬接受IA BoNT A(n = 19)或IA安慰剂(n = 16)治疗。在治疗前(基线)以及治疗后2周和8周采集血清和SF样本,并评估骨关节炎疼痛。使用测力平台、赫尔辛基慢性疼痛指数和关节触诊评估骨关节炎疼痛。在对照犬安乐死后获取滑液样本。比较IA BoNT A组和安慰剂组中SP和PGE浓度相对于基线的变化。比较骨关节炎关节和对照关节之间的滑液SP和PGE浓度。评估SP、PGE、骨关节炎疼痛与犬的体征之间的关联。
IA BoNT A治疗后,SP或PGE相对于基线无显著变化。与对照关节相比,骨关节炎关节的滑液PGE显著更高。滑液PGE与骨关节炎疼痛相关。未发现SP或PGE与犬的体征之间存在关联。所有样本中TNF-α的浓度均低于检测限。
结果表明,IA BoNT A在关节中的抗伤害感受作用可能与抑制SP和PGE无关。滑液PGE而非SP可能是犬慢性骨关节炎和疼痛的标志物。